Asset Dedication LLC’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24
Closed -$1.25K 1279
2026
Q1
$1.25K Hold
24
﹤0.01% 1006
2025
Q4
$1.41K Hold
24
﹤0.01% 1029
2025
Q3
$1.34K Hold
24
﹤0.01% 1052
2025
Q2
$1.24K Hold
24
﹤0.01% 1069
2025
Q1
$1.41K Hold
24
﹤0.01% 989
2024
Q4
$1.73K Hold
24
﹤0.01% 979
2024
Q3
$1.92K Hold
24
﹤0.01% 1013
2024
Q2
$1.72K Hold
24
﹤0.01% 1073
2024
Q1
$2K Hold
24
﹤0.01% 906
2023
Q4
$2K Hold
24
﹤0.01% 915
2023
Q3
$2K Hold
24
﹤0.01% 910
2023
Q2
$2K Hold
24
﹤0.01% 881
2023
Q1
$2K Hold
24
﹤0.01% 874
2022
Q4
$2K Hold
24
﹤0.01% 895
2022
Q3
$2K Hold
24
﹤0.01% 848
2022
Q2
$2K Hold
24
﹤0.01% 469
2022
Q1
$3K Hold
24
﹤0.01% 838
2021
Q4
$3K Hold
24
﹤0.01% 824
2021
Q3
$3K Buy
+24
New +$2.92K ﹤0.01% 884

Other funds holding TECH

Asset Dedication LLC's TECH Position: Q2 2026 in Review

Asset Dedication LLC sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 24 shares — an estimated $1.25K sold.

Asset Dedication LLC first reported a position in TECH in Q3 2021 and held it in 19 quarters. The position peaked at $3K in Q1 2022. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Asset Dedication LLC reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Asset Dedication LLC sold 24 Bio-Techne shares in Q2 2026, an estimated $1.25K.
  • Asset Dedication LLC first reported a position in Bio-Techne in Q3 2021 and held it in 19 quarters.
  • Asset Dedication LLC's Bio-Techne position peaked at $3K in Q1 2022.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.